156 related articles for article (PubMed ID: 6502318)
1. Cloxacillin absorption and disposition in cystic fibrosis.
Spino M; Chai RP; Isles AF; Thiessen JJ; Tesoro A; Gold R; MacLeod SM
J Pediatr; 1984 Nov; 105(5):829-35. PubMed ID: 6502318
[TBL] [Abstract][Full Text] [Related]
2. Theophylline disposition in cystic fibrosis.
Isles A; Spino M; Tabachnik E; Levison H; Thiessen J; MacLeod S
Am Rev Respir Dis; 1983 Apr; 127(4):417-21. PubMed ID: 6838048
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of flucloxacillin and cloxacillin in healthy subjects and patients on chronic intermittent haemodialysis.
Nauta EH; Mattie H
Br J Clin Pharmacol; 1975 Apr; 2(2):111-21. PubMed ID: 1234495
[TBL] [Abstract][Full Text] [Related]
4. Altered prednisolone pharmacokinetics in patients with cystic fibrosis.
Dove AM; Szefler SJ; Hill MR; Jusko WJ; Larsen GL; Accurso FJ
J Pediatr; 1992 May; 120(5):789-94. PubMed ID: 1578318
[TBL] [Abstract][Full Text] [Related]
5. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers.
Jiao Y; Kim TH; Tao X; Kinzig M; Landersdorfer CB; Drescher SK; Sutaria DS; Moya B; Holzgrabe U; Sörgel F; Bulitta JB
Eur J Pharm Sci; 2018 Oct; 123():416-428. PubMed ID: 30076955
[TBL] [Abstract][Full Text] [Related]
6. Serum unbound levels of cloxacillin and erythromycin in cystic fibrosis.
Valman HB; Evans KE
Arch Dis Child; 1970 Oct; 45(243):686-9. PubMed ID: 5477683
[TBL] [Abstract][Full Text] [Related]
7. Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis.
Alván G; Beermann B; Hjelte L; Lind M; Lindholm A; Strandvik B
Clin Pharmacol Ther; 1988 Oct; 44(4):436-41. PubMed ID: 3168395
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis: enhanced theophylline metabolism may be linked to the disease.
Knoppert DC; Spino M; Beck R; Thiessen JJ; MacLeod SM
Clin Pharmacol Ther; 1988 Sep; 44(3):254-64. PubMed ID: 3046811
[TBL] [Abstract][Full Text] [Related]
9. Drug disposition in cystic fibrosis.
Rey E; Tréluyer JM; Pons G
Clin Pharmacokinet; 1998 Oct; 35(4):313-29. PubMed ID: 9812180
[TBL] [Abstract][Full Text] [Related]
10. Dicloxacillin and cloxacillin: pharmacokinetics in healthy and hemodialysis subjects.
Nauta EH; Mattie H
Clin Pharmacol Ther; 1976 Jul; 20(1):98-108. PubMed ID: 1277730
[TBL] [Abstract][Full Text] [Related]
11. Ceftazidime disposition in acute and stable cystic fibrosis.
Leeder JS; Spino M; Isles AF; Tesoro AM; Gold R; MacLeod SM
Clin Pharmacol Ther; 1984 Sep; 36(3):355-62. PubMed ID: 6432400
[TBL] [Abstract][Full Text] [Related]
12. Bromide pharmacokinetics in cystic fibrosis.
Miller ME; Kornhauser DM
Arch Pediatr Adolesc Med; 1994 Mar; 148(3):266-71. PubMed ID: 8130858
[TBL] [Abstract][Full Text] [Related]
13. Diuretic effect and disposition of furosemide in cystic fibrosis.
Prandota J; Smith IJ; Hilman BC; Wilson JT
Eur J Clin Pharmacol; 1991; 40(4):333-41. PubMed ID: 2050167
[TBL] [Abstract][Full Text] [Related]
14. Rapid methylprednisolone clearance in a patient with cystic fibrosis.
Green CG; Kraus CK; Lemanske RF; Farrell PM; Jusko WJ
Drug Intell Clin Pharm; 1988 Nov; 22(11):876-8. PubMed ID: 3234253
[TBL] [Abstract][Full Text] [Related]
15. The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adults.
Ziemniak JA; Assael BM; Padoan R; Schentag JJ
Eur J Clin Pharmacol; 1984; 26(2):183-9. PubMed ID: 6723756
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of famotidine in patients with cystic fibrosis.
Maish WA; McCubbin MM; Letzig LG; Farrar HC; Kearns GL
J Clin Pharmacol; 1998 Nov; 38(11):1010-6. PubMed ID: 9824781
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis.
Geller DE; Pitlick WH; Nardella PA; Tracewell WG; Ramsey BW
Chest; 2002 Jul; 122(1):219-26. PubMed ID: 12114362
[TBL] [Abstract][Full Text] [Related]
18. Absorption of antibiotics in cystic fibrosis.
Valman HB
Arch Dis Child; 1970 Apr; 45(240):275. PubMed ID: 5420004
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics of cloxacillin in patients on chronic intermittent haemodialysis and in healthy subjects.
Nauta EH; Mattie H; Goslings WR
Chemotherapy; 1973; 19(5):261-71. PubMed ID: 4595633
[No Abstract] [Full Text] [Related]
20. Probenecid pharmacokinetics in cystic fibrosis.
Weber A; de Groot R; Ramsey B; Williams-Warren J; Smith A
Dev Pharmacol Ther; 1991; 16(1):7-12. PubMed ID: 1879255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
